Details for New Drug Application (NDA): 088171
✉ Email this page to a colleague
NDA 088171 describes FLUOTREX, which is a drug marketed by Savage Labs and is included in four NDAs. Additional details are available on the FLUOTREX profile page.
The generic ingredient in FLUOTREX is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
The generic ingredient in FLUOTREX is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
Summary for 088171
| Tradename: | FLUOTREX |
| Applicant: | Savage Labs |
| Ingredient: | fluocinolone acetonide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 088171
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;TOPICAL | Strength | 0.01% | ||||
| Approval Date: | Mar 9, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
